Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.22
-0.09 (-1.51%)
At close: Aug 1, 2025, 4:00 PM
6.21
0.00 (-0.08%)
After-hours: Aug 1, 2025, 4:00 PM EDT
Ligand Pharmaceuticals Employees
Inogen had 766 employees as of December 31, 2024. The number of employees decreased by 68 or -8.15% compared to the previous year.
Employees
766
Change (1Y)
-68
Growth (1Y)
-8.15%
Revenue / Employee
$443,812
Profits / Employee
-$35,880
Market Cap
166.97M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 766 | -68 | -8.15% |
Dec 31, 2023 | 834 | -192 | -18.71% |
Dec 31, 2022 | 1,026 | 5 | 0.49% |
Dec 31, 2021 | 1,021 | 83 | 8.85% |
Dec 31, 2020 | 938 | -82 | -8.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INGN News
- 15 days ago - Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
- 5 weeks ago - Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy - Business Wire
- 2 months ago - Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough - Benzinga
- 3 months ago - Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Inogen Announces First Quarter 2025 Financial Results - Business Wire
- 4 months ago - Inogen To Present at 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 5 months ago - A Volatile Share Price Masks Some Of The Progress At Inogen - Seeking Alpha
- 5 months ago - What's Going On With MedTech Focused Inogen Stock On Wednesday? - Benzinga